SGN Nanopharma

SGN Nanopharma is an innovation-driven, clinical-stage nanopharmaceutical company focused on creating impactful, first-class nanotherapies to address significant unmet medical needs while reducing the cost and time of commercialization. Current prevailing monotherapies (at best partially effective) remain unable to treat chronic diseases, resulting in a continued unmet medical demand. The company’s goal is to select and bring to market high-quality combination nanomedicines with clinical differentiation to alleviate unmet medical needs in major therapeutic areas, thereby making the greatest impact on patients.